FindTrial
Sign In

The role of FABP4 in renal interstitial fibrosis

The role of FABP4 in renal interstitial fibrosis

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1900022567
Enrollment
Unknown
Registered
2019-04-17
Start date
2019-04-20
Completion date
Unknown
Last updated
2019-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

IgAN

Interventions

IgAN T0:pathological staining
IgAN T1:pathological staining
IgAN T2:pathological staining

Sponsors

West China Hospital, Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: The different stage of IgAN patients who were diagnosis by renal biopsy (n=36) were enrolled in this analysis.

Exclusion criteria

Exclusion criteria: Non-IgAN

Design outcomes

Primary

MeasureTime frame
FABP4 IHC;FABP4 IF;—

Countries

China

Contacts

Public ContactLiang Ma

West China Hospital, Sichuan University

liang_m@scu.edu.cn+86 18981933920

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026